Delivery Order SPE2DB20D1102-SPE2DB24FC6GD

Award Date 4/2/24
Potential Completion Date 4/3/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4,563,851 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, with a ceiling value of $8,140.35. The contract has a period of performance through March 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,562,437,539 units of pantoprazole sodium delayed-release 40 mg tablets. The contract has a ceiling value of $24,712.02 and a completion date of October 11, 2023. It is a firm-fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,368,146 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a ceiling value of $1,075.96 and an ultimate completion date of June 29, 2023. This contract is not designated as a set-aside and was awarded as a firm-fixed-price contract. AmerisourceBergen holds a larger Indefinite...
This is a $8,769.52 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,697,881 units of pantoprazole sodium delayed-release 40 mg tablets. It has an ultimate completion date of September 6, 2024. This order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December...
This contract award, valued at $24,742.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,174,886 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 20, 2024. The $1,024.75 firm fixed-price delivery order is for the supply of 4,566,777,842 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a completion date of December 23, 2024 and was not designated with a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.78 firm-fixed-price delivery order is for the supply of 4,566,778,926 units of Pantoprazole Sodium Delayed-Release 40 mg tablets in 90-count bottles. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024. This delivery order is part of a larger $999,999,999...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,451,658 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count containers. The contract has a ceiling value of $1,132.94 and a completion date of May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,731.32 Firm Fixed Price Delivery Order is for the supply of 4,566,372,173 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,090.76 firm-fixed-price delivery order is for the purchase of 4,567,105,224 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000 count bottles. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB24FC6GD
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,145,768 units of Pantoprazole Sodium Delayed Release 40 mg Tablets. The contract has a ceiling value of $2,217.65 and a period of performance through April 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corporation, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 7/2/24, 2:10 PM